Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 98.50M
March 31, 2026 97.48M
December 31, 2025 97.35M
September 30, 2025 96.00M
June 30, 2025 92.57M
March 31, 2025 88.46M
December 31, 2024 87.47M
September 30, 2024 83.91M
June 30, 2024 83.03M
March 31, 2024 82.90M
December 31, 2023 82.73M
September 30, 2023 81.52M
June 30, 2023 81.10M
March 31, 2023 79.44M
December 31, 2022 75.51M
September 30, 2022 75.48M
June 30, 2022 73.23M
March 31, 2022 72.36M
December 31, 2021 71.25M
September 30, 2021 65.97M
June 30, 2021 62.51M
March 31, 2021 58.94M
December 31, 2020 57.54M
September 30, 2020 58.66M
June 30, 2020 62.14M
Date Value
March 31, 2020 64.44M
December 31, 2019 65.62M
September 30, 2019 64.73M
June 30, 2019 62.27M
March 31, 2019 61.25M
December 31, 2018 59.53M
September 30, 2018 56.89M
June 30, 2018 55.20M
March 31, 2018 53.20M
December 31, 2017 51.40M
September 30, 2017 50.47M
June 30, 2017 49.05M
March 31, 2017 47.27M
December 31, 2016 45.33M
September 30, 2016 44.96M
June 30, 2016 44.05M
March 31, 2016 41.73M
December 31, 2015 40.81M
September 30, 2015 38.91M
June 30, 2015 37.08M
March 31, 2015 37.52M
December 31, 2014 36.63M
September 30, 2014 35.93M
June 30, 2014 34.55M
March 31, 2014 33.56M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Globus Medical, Inc. 147.06M
Glaukos Corp. 177.17M
Baxter International, Inc. 480.00M
Becton, Dickinson & Co. 1.135B
DexCom, Inc. 604.00M